Drug Manufacturers—General Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 11 |  LLY Eli Lilly and Company Common Stock | 1247.64 USD | -0.57% | +3.95% | +3.88% | +75.60% | 1.17 T USD | ||
| 19 |  JNJ Johnson & Johnson Common Stock | 273.08 USD | +1.03% | +1.73% | +4.01% | +52.14% | 658.10 B USD | ||
| 22 |  ABBV AbbVie Inc. Common Stock | 264.56 USD | -0.14% | +4.18% | +2.28% | +25.80% | 467.51 B USD | ||
| 33 |  MRK Merck & Company, Inc. Common Stock | 150.69 USD | -1.20% | +9.70% | +14.98% | +73.15% | 371.78 B USD | ||
| 42 |  NVS Novartis AG | 157.99 USD | -0.55% | +2.84% | +0.91% | +24.60% | 301.47 B USD | ||
| 59 |  AMGN Amgen Inc. - Common Stock | 443.79 USD | +1.02% | +5.82% | +17.23% | +51.67% | 239.93 B USD | ||
| 84 |  GILD Gilead Sciences, Inc. - Common Stock | 146.74 USD | +0.42% | +5.63% | +12.02% | +27.70% | 181.95 B USD | ||
| 102 |  PFE Pfizer, Inc. Common Stock | 27.98 USD | -0.32% | +3.06% | +13.88% | +8.16% | 159.48 B USD | ||
| 113 |  BMY Bristol-Myers Squibb Company Common Stock | 67.29 USD | +0.40% | +2.58% | +7.84% | +40.30% | 137.45 B USD | ||
| 140 |  GSK GSK plc American Depositary Shares | 51.80 USD | -1.18% | +2.01% | -0.46% | +18.13% | 111.77 B USD | ||
| 141 |  SNY Sanofi - American Depositary Shares | 45.66 USD | -0.41% | +2.81% | +4.41% | -10.63% | 111.36 B USD | ||
| 370 |  ONC BeOne Medicines Ltd - American Depositary Shares | 371.98 USD | -0.66% | +2.61% | +13.50% | +17.83% | 42.29 B USD | ||
| 442 |  BIIB Biogen Inc. - Common Stock | 218.02 USD | +0.57% | +4.24% | +7.53% | +56.84% | 32.21 B USD | ||
| 1131 |  CGON CG Oncology, Inc. - Common stock | 78.24 USD | -1.97% | +1.47% | +10.34% | +79.61% | 6.94 B USD | ||
| 1139 |  ORKA Oruka Therapeutics, Inc. - Common Stock | 102.39 USD | -5.16% | -9.12% | +11.66% | +219.27% | 6.78 B USD | ||
| 1496 |  MANE Veradermics, Incorporated Common Stock | 98.33 USD | -4.48% | -9.16% | -10.81% | +197.97% | 4.11 B USD | ||
| 1589 |  OGN Organon & Co. Common Stock | 13.76 USD | 0.00% | +0.36% | +1.78% | +89.53% | 3.61 B USD | ||
| 1682 |  MBX MBX Biosciences, Inc. - Common Stock | 66.46 USD | +0.20% | -2.62% | +6.78% | +366.06% | 3.20 B USD | ||
| 1892 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 49.36 USD | +2.32% | +1.94% | +20.95% | +88.47% | 2.37 B USD | ||
| 1935 |  GENB Generate Biomedicines, Inc. - Common Stock | 17.71 USD | +9.86% | +12.87% | +29.84% | +18.07% | 2.27 B USD |
Noticias Drug Manufacturers—General Stocks
Roche y Eli Lilly reciben autorización de la FDA para prueba del Alzheimer
La CE aprueba la combinación Trodelvy-Keytruda para el TNBC
Eli Lilly lanza su pastilla para adelgazar Foundayo en Reino Unido
GSK obtiene aprobación en Japón para fármaco contra hepatitis B y revisión de la FDA
La FDA acepta la solicitud de GSK para Jemperli en cáncer de recto
Hibsago de GSK obtiene su primera aprobación global en Japón para la hepatitis B
ATAI Beckley presenta resultados antes de su adquisición por Eli Lilly
Gainers Drug Manufacturers—General Stocks
 VBIO Valion Bio, Inc. - Common stock | 0.16 | +33.33% |
GENB Generate Biomedicines, Inc. - Common Stock | 17.71 | +9.86% |
 PPCB Propanc Biopharma, Inc. - Common Stock | 1.16 | +7.41% |
 DWTX Dogwood Therapeutics, Inc. - Common Stock | 2.65 | +6.43% |
 ERNAW Ernexa Therapeutics Inc. - Warrants | 0.0600 | +6.38% |
 MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.80 | +5.26% |
 PTHS Pelthos Therapeutics Inc. Common Stock | 26.59 | +3.18% |
 PVLA Palvella Therapeutics, Inc. - Common Stock | 145.85 | +2.68% |
Losers Drug Manufacturers—General Stocks
 KAPA Kairos Pharma, Ltd. Common Stock | 0.24 | -17.24% |
 PLYX Polaryx Therapeutics, Inc. - Common Stock | 1.88 | -9.18% |
 EXOZ eXoZymes Inc. - Common Stock | 6.95 | -5.83% |
 QCLS Q/C Technologies, Inc. - Common Stock | 2.43 | -5.81% |
 UPB Upstream Bio, Inc. - Common Stock | 6.59 | -5.45% |
ORKA Oruka Therapeutics, Inc. - Common Stock | 102.39 | -5.16% |
MANE Veradermics, Incorporated Common Stock | 98.33 | -4.48% |
 MDCX Medicus Pharma Ltd. - Common Stock | 0.26 | -3.70% |